Tuesday, February 25, 2020

USFDA issues warning letter to Cipla for Goa manufacturing facility

USFDA issues warning letter to Cipla for Goa manufacturing facility The company further said that it remains committed to maintaining the highest standards of compliance and will work closely with the agency to comprehensively address all the observations

from Moneycontrol Business News https://ift.tt/2wNZJKI

No comments:

Post a Comment

Bulls return to D-Street as falling oil prices ease geopolitical jitters

Indian stock markets experienced a significant rally on Wednesday. Both the Nifty 50 and S&P BSE Sensex saw gains exceeding 1 percent. T...